Robert May

Corporate Officer/Principal at Affinia Therapeutics, Inc.

56 year

Health Technology

Consumer Services

Robert May active positions

Companies	Position	Start	End
Affinia Therapeutics, Inc. Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA.	Corporate Officer/Principal	2020-05-31	-

Career history of Robert May

Former positions of Robert May

Companies	Position	Start	End
AVEXIS INC	Corporate Officer/Principal	2017-12-31	2020-05-31
Novartis Vaccines & Diagnostics, Inc. Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.	Chief Tech/Sci/R&D Officer	-	-

Training of Robert May

University of California, Berkeley

Undergraduate Degree

Statistics

International

United States

Operational

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Private companies	3
Affinia Therapeutics, Inc. Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA.	Health Technology
Novartis Gene Therapies, Inc. Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL.	Health Technology
Novartis Vaccines & Diagnostics, Inc. Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.	Health Technology

See company connections